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Abstract— Many diseases are characterized by limitations
in mobility, including a wide range of musculoskeletal and
neurological conditions. Reduced mobility impacts a patients
ability to perform activities of daily living, which in turn reduces
health-related quality of life. Mobility can be assessed by
collecting patient-reported outcome scores from standardized
questionnaires and by directly measuring physical activity
parameters from wearable accelerometer data. In this work, we
explored the relationship between subjectively and objectively
measured mobility by training machine learning models to
predict patient responses based on features derived from real-
world acceleration data. Our method achieved up to 82%
accuracy using a random forest classifier and set the basis
to develop novel data-driven digital biomarkers for objective,
quantitative and more frequent evaluation of patients’ mobility.
I. INTRODUCTION
Improving the quality of life of patients is a core objective
of all clinical programs. Patient mobility, physical activity
(PA) and the ability to perform activities of daily living
(ADLs), such as walking, carrying groceries or bathing, are
important indicators of quality of life (QoL) [1]. This is
particularly relevant for patients affected by musculoskeletal
diseases [2]. Current clinical assessment of QoL factors
relies on patient-reported outcome (PRO) scores, standard-
ized questionnaires and diaries, which are often condition-
specific. A common questionnaire is the 36-Item Short-
Form Health Survey (SF-36). PROs are an important basis
for assessing the efficacy of clinical interventions [3], yet
these scores are subjective, biased and infrequently collected.
Recently, wearable accelerometers have been increasingly
used to monitor and quantify PA [4] and gait parameters [5],
and for activity recognition [6]. While not yet fully translated
into clinical applications, this technology allows for passive
monitoring over a long period of time, outside the clinic,
and hence it is highly valuable in evaluating the patient’s
everyday mobility [7]. Yet the relationship between the
aforementioned objective measures and the patient perceived
mobility and related impact on QoL has not been thoroughly
investigated [8]. In this work, we explore the feasibility of
predicting PROs on PA (from a subset of answers to SF-
36) from passively acquired, real-world mobility data from a
wearable accelerometer, using machine learning models. We
aim to provide novel objective scores of mobility to evaluate
the patient status and quantify treatment efficacy.
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II. MATERIAL AND METHODS
Data: We considered a total of 165 patients (51% female
and 49% male, 70-95 years of age, median 79) affected
by a chronic and degenerating musculoskeletal condition.
These patients are enrolled in an ongoing clinical trial and
hence further information cannot be disclosed. All Ethics
Committees involved in the study granted approval and
written consent was given by every participant. Patients were
asked on a monthly basis, for up to 6 months, to fill in the
SF-36 Health Survey and to wear the actibelt sensor (Trium
Analysis Online GmbH, Germany) around their waist for
at least one continuous week prior to each survey answer.
The actibelt system continuously collects 3D accelerations
via tri-axial accelerometer of range ±6 g from the center
of gravity of the subject at 100 Hz. Gait speed, activity
counts, walked distance, number of steps and wear-time are
then derived at 1 Hz. To validate the proposed prediction
of general mobility scores, we selected the following subset
of SF-36 questions that are directly related to PA: (walking)
”Does your health now limit you in walking more than a
mile [Q1] / one hundred yards [Q2] / several hundred yards
[Q3]? If so how much?”; (ADLs) ”During the past week, how
much of the time have you cut down on the amount of time
you spent on [Q4] / had difficulty performing [Q5] work or
other activities as a result of your physical health?”. At each
assessment time t, multiple-choice answers were converted
to an integer score q(t): (Q1-3) Yes, limited a lot (q = 0)
/ yes, limited a little (1) / no, not limited at all (2); (Q4-5)
All of the time (q = 0) / most of the time (1) / some of the
time (2) / a little of the time (3) / none of the time (4).
Features: A total of 162 clinically relevant acceleration
features were considered as predictors, namely: mean, me-
dian, standard deviation, 5th and 95th percentiles of speed,
activity count and walked distance; and total number of steps,
activity counts and walked distance. We computed daily
summary features from the day when the patient filled in
the SF-36 survey d0 to one week prior to it {d−7, . . . , d−1},
and weekly ones over [d−7, . . . , d0]. For this population
strong day-to-day variation is not expected, therefore data for
missing days were replaced by averages over the previous 7
days, allowing for gaps of at most 2 consecutive days.
Prediction: For each patient k, assessment t and ques-
tion i, we converted answers qk,i(t) to binary classes to
define targets yk,i(t), see Tab. I. This conversion was based
on the distribution and clinical relevance of answers. We
also fused the targeted questions into walking (Q1-3) and
other ADLs (Q4-5) questions, calculated new scores as
TABLE I
SUMMARY OF THE RF CLASSIFICATION RESULTS.
PRO question Target Class distribution F1 scores Accuracy
Q1 y = 0 if q = 0 0.28 0.40 0.75 ± 0.08
y = 1 if q ∈ {1, 2} 0.72 0.84
Q2 y = 0 if q ∈ {0, 1} 0.27 0.29 0.76 ± 0.09
y = 1 if q = 2 0.73 0.85
Q3 y = 0 if q ∈ {0, 1} 0.38 0.43 0.69 ± 0.08
y = 1 if q = 2 0.62 0.77
Q1/Q2/Q3 y = 0 if q ∈ {0, 1, 2} 0.21 0.32 0.82 ± 0.07
y = 1 if q ∈ {3, . . . , 6} 0.79 0.89
Q1/Q2/Q3
y = 0 if q ∈ {0, 1, 2} 0.21 0.42
0.60 ± 0.10y = 1 if q ∈ {3, 4} 0.22 0.07
y = 2 if q ∈ {5, 6} 0.57 0.72
Q4 y = 0 if q ∈ {0, 1, 2} 0.24 0.10 0.74 ± 0.11
y = 1 if q ∈ {3, 4} 0.76 0.84
Q5 y = 0 if q ∈ {0, 1, 2} 0.32 0.35 0.70 ± 0.09
y = 1 if q ∈ {3, 4} 0.68 0.79
Q4/Q5 y = 0 if q ∈ {0, . . . , 4} 0.22 0.09 0.75 ± 0.11
y = 1 if q ∈ {5, . . . , 8} 0.78 0.85
Q4/Q5
y = 0 if q ∈ {0, 1, 2} 0.05 0.00
0.66 ± 0.12y = 1 if q ∈ {3, 4, 5} 0.26 0.06
y = 2 if q ∈ {6, 7, 8} 0.69 0.79
the sum of the individual ones, and defined new binary
and 3-class targets. Based on the aforementioned features
X ∈ R162×516, we predicted PRO targets y(q) by training
binary and 3-class random forest (RF) classifiers. Individual
models were trained and validated using patient-stratified
10-fold cross-validation (CV), to predict each yk,i(t), with
i ∈ {1; . . . ; 5;walk ;ADL}. Hyperparameters were selected
via nested 10-fold CV randomized search.
III. RESULTS
Table I summarizes the mean accuracy and classes F1
score for all considered targets on the left-out patient groups.
For individual questions on walking (other ADLs) accuracy
ranged from 69% to 76% (70% to 74%). When fusing
answers to similar questions, accuracy increases to 82% and
75% for walking and other ALDs outcome scores, respec-
tively. For all prediction tasks, F1 scores of the majority
class are higher than the minority ones. Binary RF classifiers
were compared to support vector machine (SVM) models
with 3rd-degree radial basis function kernel, trained using
the same approach. SVM achieved slightly lower accuracies
of 0.76±0.07 and 0.72±0.07 for walking and other ADLs,
respectively, but higher F1 scores for y = 0, with F1s of
[0.40, 0.85] and [0.32, 0.81].
IV. DISCUSSION
The proposed RF classifiers can accurately and robustly
predict PRO scores on ADLs, with an accuracy between 69%
and 82%. The most predictive features were speed standard
deviation, walked distance and activity counts features, and
number of steps. When observing individual classes, results
for class y = 0 are significantly poorer. This might be
due to the much smaller representation of this class in our
dataset. Principal component analysis (PCA) allows us to
visualize the original high-dimensional X by projecting it
onto two dimensions. Fig.1 shows X after projection onto
the first 2 PCA components for Q1. The subjective nature
of SF-36 and the limited amount of observations, especially
for the minority class, could contribute to the fact that no
clear clusters can be easily identified and reflect the lower
F1 scores. Compared to SVM, the success of RFs in our
experiments is partially enabled by the robustness of RF to
class imbalances. Data augmentation and oversampling of the
minority class might improve performance. Grouping similar
questions defines more general mobility scores, which are
less subject to patient’s biases, reflected in the better results
versus individual questions.
Fig. 1. First and second PCA components ofX and corresponding y1 (Q1).
V. CONCLUSIONS
We presented a novel approach towards quantifying and
objectifying scores to evaluate patient mobility and capability
of performing ADLs. Our method is based on predicting
PROs from the SF-36 Health Survey, using random forest
classifiers trained on features extracted from wearable ac-
celerometer data. An accuracy of up to 82% was achieved.
The subjective nature of the survey, the difficulty for patients
to objectively answer to quantitative questions, and their
impact on our results should be further investigated. Future
work will focus on collecting more data, exploring deep
learning approaches and temporal prediction, and formulat-
ing different definitions of QoL mobility functions.
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